HopeStage
Back to overview

Bipolarity studies

Topics
More filters

Bipolarity

Bipolarity involves episodes of depression and periods of elevated or irritable mood, with unusually high energy and activity.

1979studies shown
Showing 1,249-1,260 of 1,979
Drug study icon
CompletedNCT05481957

Vortioxetine Adjunctive Treatment in Depression in bipolarity

What is this study about?

Researchers compared Vortioxetine and valprote to find out how the approaches affected depression symptoms in people with bipolarity during a depressive episode.

This study has finished and is no longer accepting participants.

In Hangzhou
Bipolarity, DepressionMedication studyAges 14–45
Countries
China
Sponsor
First Affiliated Hospital of Zhejiang University
Drug study icon
TerminatedNCT00374543

Ziprasidone for Generalized Anxiety in people with Bipolarity

Official study title

Ziprasidone for the Treatment of Generalized Anxiety Comorbidity in Patients With Bipolar Disorder

This study ended early.

In Boston
Bipolarity, AnxietyMedication studyAges 18–75
Countries
United States
Sponsor
Massachusetts General Hospital (Hospital / academic medical center)
Drug study icon
CompletedNCT00034229

study of Felbamate for Treatment-Resistant Depression in bipolarity

Official study title

A Double-Blind Randomized Placebo-Controlled Trial of Felbamate in Treatment Resistant Bipolar Depression

This study has finished and is no longer accepting participants.

In Bethesda
Bipolarity, DepressionMedication study
Countries
United States
Sponsor
National Institute of Mental Health (NIMH) (Government agency)
Drug study icon
CompletedNCT00025792

study of Pramipexole in Depression in bipolarity

Official study title

An Investigation of the Antidepressant Efficacy of a Dopamine Agonist With Neurotrophic Properties in Bipolar Disorder

This study has finished and is no longer accepting participants.

In Bethesda
Bipolarity, DepressionMedication study
Countries
United States
Sponsor
National Institute of Mental Health (NIMH) (Government agency)
Drug study icon
CompletedNCT00001146

Omega-3 Fatty Acids in the Treatment of Bipolarity: A study

Official study title

Omega-3 Fatty Acids in the Treatment of Major Depression and Bipolar Disorder: A Double-Blind, Placebo-Controlled Trial

This study has finished and is no longer accepting participants.

In Bethesda
Bipolarity, DepressionMedication study
Countries
United States
Sponsor
National Institute of Mental Health (NIMH) (Government agency)
Drug study icon
CompletedNCT00789113

Determination of Absorption and Elimination of Lamotrigine-XR

Official study title

Determination of Bioavailability and Clearance of Lamotrigine-XR by a Stable Isotope Technique

This study has finished and is no longer accepting participants.

In Minneapolis
Bipolarity, DepressionMedication studyAges 65+
Countries
United States
Sponsor
University of Minnesota
Drug study icon
CompletedNCT00242619

Insulin Resistance in people with Mood Disorder

Official study title

Rosiglitazone Add-On in Treatment of Depressed Patients With Insulin Resistance: a Pilot Study

This study has finished and is no longer accepting participants.

In Stanford
Bipolarity, DepressionMedication studyAges 18–60
Countries
United States
Sponsor
Stanford University
Device study icon
CompletedNCT05375214

iTBS in Bipolar I Depression

Official study title

A Pilot Study of iTBS in Bipolar I Depression

This study has finished and is no longer accepting participants.

Multiple locations, including Baltimore
Bipolarity, DepressionDevice studyAges 22–65
Countries
United States
Sponsor
Johns Hopkins University

Registry coverage

We gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.